🔬At IndieBio NY, we’re backing the scientists redefining the future of biotechnology.
As SOSV’s early-stage life sciences and therapeutics program in the heart of New York City, we specialize in translating science into real-world impact. Our 25,000 sq. ft. facility in NYC was purpose-built for biotech founders, complete with BSL 1 & 2 labs, molecular and cell biology capabilities, protein purification, and scale-up from 1 to 25L.
But space is just the start. We also offer:
💸 $525,000 initial investment + follow-on capital
🧪 Scientific mentorship
📈 Commercialization expertise
🧬 A network of partners across academia, industry, and venture
And so much more...
We’re scientists ourselves. Our team knows what it takes to de-risk breakthrough science and navigate the path to market:
▪️Stephen Chambers – Managing Director of IBNY, SOSV GP, PhD in Molecular Biology, founding scientist at Vertex (IPO in 1991), led multiple drugs through FDA approval
▪️Deborah Zajac – SOSV GP, 20+ years in VC and startups, supporting dozens of corporations and over 15 venture funds
▪️Sabriya Stukes, PhD – CSO of IBNY, PhD in Biomedical Sciences, former biotech operator, educator, and translational medicine expert
(see our website for bios on the entire fantastic and dedicated team!)
Thank you to the brilliant teams in our portfolio who are pushing boundaries. A few, featured in this video, include:
TômTex Inc. (Ross McBee), Helex (Dr Poulami Chaudhuri), Cayuga Biotech (Damien Kudela), Sequentialbio (Oliver Worsley, PhD), NuKoKo (Ross Newton), CroBio (Wayne Mulhall ), FREZENT Biological Solutions (Natasha Shtraizent, PhD), BioLattice (Amelia Z.), Bioeutectics (Tomas Silicaro), Vitarka Therapeutics (Vineeta Tripathi), Mothership Materials (Jo Marini)
Check out what we’re all about 🎥👇
If you're getting ready to launch a life sciences (therapeutics, med device, etc.) tech startup, get in touch! 👉
sosv.com/programs/
#BuildWithSOSV #DeepTech #LifeSciences